Pulmovant

We are Pulmovant, a clinical-stage biotechnology company that is singularly focused on transforming the treatment paradigm for patients with pulmonary diseases. Our first investigational product, mosliciguat, is a potential first-in-class soluble guanylate cyclase (sGC) activa…